In vitro bactericidal and in vivo therapeutic activities of a new rifamycin derivative, KRM-1648, against Mycobacterium tuberculosis (Q28379172)
scientific article
Language:
(P31) (Q13442814)
(P304) 426-428
(P407) (Q1860)
(P433) 2
(P478) 40
(P577) Thursday, February 1, 1996
(P921) (Q130971)
(P1433) (Q578004)
(P1476) "In vitro bactericidal and in vivo therapeutic activities of a new rifamycin derivative, KRM-1648, against Mycobacterium tuberculosis" (language: en)
(P2093) Yamamoto T
Amitani R
Suzuki K
Tanaka E
Murayama T
Kuze F
(P2860) (Q28378656)
(Q28368360)
(Q28368095)
(Q28329793)
(Q28329627)
(Q28327994)
(Q28335333)
(Q28330319)
(Q42271084)
(Q42270686)
(Q42246715)
(Q42244885)
(Q42200392)
(Q41335968)
(Q52633126)
(Q44136692)
(Q93792500)
(Q71710180)
(Q71545075)
(Q76846930)
other details
description scientific article

External Links